Univariate analysis identified primary therapy outcome (p < 0.001), age (p = 0.032), residual tumor (p < 0.001), ATP1A3 (p < 0.001), and ATP1A4 (p = 0.03) as prognostic factors for OS (Table 2). The gene discussed is ATP1A3; the disease is neoplasm.